Literature DB >> 12479854

Effects of flavonoids on cisplatin-induced apoptosis of HL-60 and L1210 leukemia cells.

Lubos Cipák1, Peter Rauko, Eva Miadoková, Ingrid Cipáková, Ladislav Novotný.   

Abstract

Effects of three flavonoids, quercetin (QU), galangin (GA), and chrysin (ChR) on cisplatin (cis-Pt)-induced apoptosis of human promyelocytic leukemia HL-60 cells and murine leukemia L1210 cells were investigated. The quantitative analysis of apoptotic DNA fragmentation was used to show that preincubation of cells with flavonoids can influence cis-Pt-induced apoptosis in different way. ChR had no effect, QU enhanced, and GA reduced apoptotic DNA fragmentation. It is also shown that combined treatment with QU and cis-Pt showed synergistic effect, however, GA combined with cis-Pt exhibited antagonism on cytotoxicity in L1210 murine leukemia cells. We assume that tested flavonoids affect the important biological activities connected with cancer chemotherapy and chemoprevention as they differently modulated the sensitivity of cells to cis-Pt treatment. QU is presented as pro-apoptotic agent and GA as agent with anti-apoptotic potential.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12479854     DOI: 10.1016/s0145-2126(02)00063-2

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  14 in total

1.  Ethyl acetate extract and its major constituent, isorhamnetin 3-O-rutinoside, from Nitraria retusa leaves, promote apoptosis of human myelogenous erythroleukaemia cells.

Authors:  J Boubaker; W Bhouri; M Ben Sghaier; K Ghedira; M G Dijoux Franca; L Chekir-Ghedira
Journal:  Cell Prolif       Date:  2011-10       Impact factor: 6.831

2.  Galangin: A metabolite that suppresses anti-neoplastic activities through modulation of oncogenic targets.

Authors:  Hardeep Singh Tuli; Katrin Sak; Shubham Adhikary; Ginpreet Kaur; Diwakar Aggarwal; Jagjit Kaur; Manoj Kumar; Nidarshana Chaturvedi Parashar; Gaurav Parashar; Uttam Sharma; Aklank Jain
Journal:  Exp Biol Med (Maywood)       Date:  2021-12-14

3.  The investigation of effects of quercetin and its combination with Cisplatin on malignant mesothelioma cells in vitro.

Authors:  A Demiroglu-Zergeroglu; B Basara-Cigerim; E Kilic; G Yanikkaya-Demirel
Journal:  J Biomed Biotechnol       Date:  2010-05-17

4.  Isorhamnetin 3-O-robinobioside from Nitraria retusa leaves enhance antioxidant and antigenotoxic activity in human chronic myelogenous leukemia cell line K562.

Authors:  Jihed Boubaker; Mohammed Ben Sghaier; Ines Skandrani; Kamel Ghedira; Leila Chekir-Ghedira
Journal:  BMC Complement Altern Med       Date:  2012-08-22       Impact factor: 3.659

5.  Anticancer activity of extracts derived from the mature roots of Scutellaria baicalensis on human malignant brain tumor cells.

Authors:  Adrienne C Scheck; Krya Perry; Nicole C Hank; W Dennis Clark
Journal:  BMC Complement Altern Med       Date:  2006-08-16       Impact factor: 3.659

6.  Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles.

Authors:  Linghui Dian; Enjiang Yu; Xiaona Chen; Xinguo Wen; Zhengzan Zhang; Lingzhen Qin; Qingqing Wang; Ge Li; Chuanbin Wu
Journal:  Nanoscale Res Lett       Date:  2014-12-18       Impact factor: 4.703

7.  Exploring the anti-diabetic potential of Australian Aboriginal and Indian Ayurvedic plant extracts using cell-based assays.

Authors:  Vandana Gulati; Pankaj Gulati; Ian H Harding; Enzo A Palombo
Journal:  BMC Complement Altern Med       Date:  2015-02-05       Impact factor: 3.659

8.  Low Doses of Cisplatin Induce Gene Alterations, Cell Cycle Arrest, and Apoptosis in Human Promyelocytic Leukemia Cells.

Authors:  Venkatramreddy Velma; Shaloam R Dasari; Paul B Tchounwou
Journal:  Biomark Insights       Date:  2016-08-24

9.  Established Human Cell Lines as Models to Study Anti-leukemic Effects of Flavonoids.

Authors:  Katrin Sak; Hele Everaus
Journal:  Curr Genomics       Date:  2017-02       Impact factor: 2.236

10.  Quercetin and Cisplatin combined treatment altered cell cycle and mitogen activated protein kinase expressions in malignant mesotelioma cells.

Authors:  Asuman Demiroglu-Zergeroglu; Emel Ergene; Nurettin Ayvali; Victor Kuete; Hulya Sivas
Journal:  BMC Complement Altern Med       Date:  2016-08-11       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.